Education
About Us
Working with TipRanks
Follow Us
Viemed Healthcare US (VMD)
:VMD
VMD Stock Chart & Stats
$6.85
$0.08(0.94%)
At close: 4:00 PM EST
$6.85
$0.08(0.94%)
Day’s Range― - ―
52-Week Range$5.93 - $9.05
Previous CloseN/A
Volume27.16K
Average Volume (3M)154.39K
Market Cap
$237.99M
Enterprise Value$290.43M
Total Cash (Recent Filing)$11.12M
Total Debt (Recent Filing)$24.70M
Price to Earnings (P/E)18.9
Beta0.85
Next Earnings
Mar 10, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding38,017,906
10 Day Avg. Volume154,887
30 Day Avg. Volume154,393
Financial Highlights & Ratios
PEG Ratio3.72
Price to Book (P/B)2.37
Price to Sales (P/S)1.39
P/FCF Ratio235.82
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit1.97
Enterprise Value/Ebitda6.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.43
Revenue Forecast (FY)$273.55M
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was $5.93 and its highest was $9.05 in the past 12 months.
What is Viemed Healthcare US’s market cap?
Viemed Healthcare US’s market cap is $237.99M.
When is Viemed Healthcare US’s upcoming earnings report date?
Viemed Healthcare US’s upcoming earnings report date is Mar 10, 2026 which is in 109 days.
How were Viemed Healthcare US’s earnings last quarter?
Viemed Healthcare US released its earnings results on Nov 05, 2025. The company reported $0.09 earnings per share for the quarter, the consensus estimate of $0.09 by $0.
Is Viemed Healthcare US overvalued?
According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued.
Does Viemed Healthcare US pay dividends?
Viemed Healthcare US does not currently pay dividends.
What is Viemed Healthcare US’s EPS estimate?
Viemed Healthcare US’s EPS estimate is 0.13.
How many shares outstanding does Viemed Healthcare US have?
Viemed Healthcare US has 38,017,906 shares outstanding.
What happened to Viemed Healthcare US’s price movement after its last earnings report?
Viemed Healthcare US reported an EPS of $0.09 in its last earnings report, expectations of $0.09. Following the earnings report the stock price went down -2.644%.
Which hedge fund is a major shareholder of Viemed Healthcare US?
Currently, no hedge funds are holding shares in VMD
Viemed Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VMD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 14.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $402.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.29%
12-Months-Change
Fundamentals
Return on Equity
10.53%
Trailing 12-Months
Asset Growth
19.37%
Trailing 12-Months
Company Description
Viemed Healthcare US
Viemed Healthcare (VMD) is a prominent provider of home healthcare services, specializing in the treatment of patients with chronic respiratory conditions. The company operates primarily in the home medical equipment sector, offering a range of products and services including respiratory therapy, equipment rental and sales, and patient monitoring solutions. Viemed is committed to improving patient outcomes through innovative healthcare solutions delivered in the comfort of patients' homes.
VMD Company Deck
VMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Viemed's strong revenue growth, successful integration of acquisitions, and expansion in sleep and maternal health segments. However, there were some concerns about gross margin pressures and narrowed revenue guidance. Overall, the positive developments in growth and expansion outweigh the negative aspects.View all VMD earnings summariesTechnical Analysis
Ownership Overview
13.31% Insiders
14.98% Mutual Funds
25.33% Other Institutional Investors
38.57% Public Companies and
Individual Investors